- Home
- HLVX vs BMGL Comparison
HLVX vs BMGL Comparison
Compare HLVX & BMGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLVX
- BMGL
- Stock Information
- Founded
- HLVX 2020
- BMGL 2001
- Country
- HLVX United States
- BMGL Singapore
- Employees
- HLVX N/A
- BMGL N/A
- Industry
- HLVX Biotechnology: Pharmaceutical Preparations
- BMGL
- Sector
- HLVX Health Care
- BMGL
- Exchange
- HLVX Nasdaq
- BMGL NYSE
- Market Cap
- HLVX 83.7M
- BMGL 78.3M
- IPO Year
- HLVX 2022
- BMGL 2025
- Fundamental
- Price
- HLVX $1.97
- BMGL $1.78
- Analyst Decision
- HLVX Hold
- BMGL
- Analyst Count
- HLVX 5
- BMGL 0
- Target Price
- HLVX $2.33
- BMGL N/A
- AVG Volume (30 Days)
- HLVX 436.7K
- BMGL 5.7M
- Earning Date
- HLVX 08-07-2025
- BMGL 01-01-0001
- Dividend Yield
- HLVX N/A
- BMGL N/A
- EPS Growth
- HLVX N/A
- BMGL N/A
- EPS
- HLVX N/A
- BMGL 0.02
- Revenue
- HLVX N/A
- BMGL $7,342,469.00
- Revenue This Year
- HLVX N/A
- BMGL N/A
- Revenue Next Year
- HLVX N/A
- BMGL N/A
- P/E Ratio
- HLVX N/A
- BMGL $90.43
- Revenue Growth
- HLVX N/A
- BMGL 2.28
- 52 Week Low
- HLVX $1.34
- BMGL $0.91
- 52 Week High
- HLVX $15.25
- BMGL $9.40
- Technical
- Relative Strength Index (RSI)
- HLVX 58.49
- BMGL N/A
- Support Level
- HLVX $1.83
- BMGL N/A
- Resistance Level
- HLVX $1.95
- BMGL N/A
- Average True Range (ATR)
- HLVX 0.08
- BMGL 0.00
- MACD
- HLVX 0.00
- BMGL 0.00
- Stochastic Oscillator
- HLVX 60.78
- BMGL 0.00
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.